SBIA
TEVA icon

Sheaff Brock Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,000
Closed -$198K – 508
2020
Q3 		$198K Sell
22,000
-500
-2% -$5.29K 0.02% 394
2020
Q2 		$277K Sell
22,500
-360
-2% -$4.07K 0.03% 320
2020
Q1 		$205K Sell
22,860
-6,000
-21% -$61.5K 0.03% 334
2019
Q4 		$283K Buy
28,860
+17,200
+148% +$154K 0.03% 346
2019
Q3 		$80K Sell
11,660
-500
-4% -$3.83K 0.01% 444
2019
Q2 		$112K Buy
12,160
+589
+5% +$7.1K 0.01% 456
2019
Q1 		$181K Buy
+11,571
New +$204K 0.02% 444
2018
Q3 		– Sell
-8,344
Closed -$203K – 556
2018
Q2 		$203K Sell
8,344
-2,000
-19% -$40.8K 0.02% 462
2018
Q1 		$177K Buy
+10,344
New +$202K 0.02% 482
2017
Q3 		– Sell
-8,389
Closed -$279K – 613
2017
Q2 		$279K Buy
8,389
+294
+4% +$9.1K 0.04% 398
2017
Q1 		$260K Buy
8,095
+177
+2% +$6.04K 0.03% 434
2016
Q4 		$287K Buy
+7,918
New +$316K 0.04% 417
2016
Q3 		– Sell
-4,708
Closed -$237K – 591
2016
Q2 		$237K Buy
4,708
+300
+7% +$16K 0.03% 437
2016
Q1 		$236K Buy
4,408
+1
+0% +$59 0.03% 447
2015
Q4 		$289K Buy
+4,407
New +$272K 0.03% 423

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Sheaff Brock Investment Advisors's TEVA Position: Q4 2020 in Review

Sheaff Brock Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 22,000 shares — an estimated $198K sold.

Sheaff Brock Investment Advisors first reported a position in TEVA in Q4 2015 and held it in 15 quarters. The position peaked at $289K in Q4 2015. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Sheaff Brock Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 22,000 Teva Pharmaceuticals shares in Q4 2020, an estimated $198K.
  • Sheaff Brock Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Sheaff Brock Investment Advisors's Teva Pharmaceuticals position peaked at $289K in Q4 2015.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.